TXN2

thioredoxin 2

Basic information

Region (hg38): 22:36467046-36481640

Links

ENSG00000100348NCBI:25828OMIM:609063HGNC:17772Uniprot:Q99757AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • combined oxidative phosphorylation defect type 29 (Supportive), mode of inheritance: AR
  • combined oxidative phosphorylation deficiency 29 (Limited), mode of inheritance: Unknown

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Combined oxidative phosphorylation deficiency 29ARBiochemicalMedical management (with coenzyme Q10) has been described as beneficialBiochemical; Neurologic26626369

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TXN2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TXN2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
10
clinvar
1
clinvar
11
missense
22
clinvar
1
clinvar
23
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
non coding
4
clinvar
4
clinvar
8
Total 0 0 23 15 5

Variants in TXN2

This is a list of pathogenic ClinVar variants found in the TXN2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
22-36467627-CCT-C Benign (May 19, 2021)1222057
22-36467804-T-G Uncertain significance (Apr 27, 2023)2879545
22-36467809-C-T not specified Uncertain significance (Jul 19, 2022)2302193
22-36467811-A-G not specified Uncertain significance (May 04, 2023)2140426
22-36467825-G-A Likely benign (May 08, 2023)1962579
22-36467836-A-G Likely benign (Dec 31, 2019)756285
22-36467860-C-A not specified Uncertain significance (Jun 10, 2024)3330358
22-36467876-G-A Likely benign (Jul 13, 2022)2427937
22-36467918-C-T not specified Uncertain significance (Jul 20, 2023)2577086
22-36467932-C-T Likely benign (Mar 13, 2022)1945062
22-36468016-G-T Benign (May 19, 2021)1271118
22-36476703-T-G Combined oxidative phosphorylation deficiency 29 Benign (Dec 05, 2021)1280669
22-36476725-A-G Likely benign (Dec 11, 2023)2962563
22-36476744-T-C Combined oxidative phosphorylation deficiency 29 • not specified Uncertain significance (Jan 31, 2023)1031205
22-36476775-C-T Likely benign (Apr 25, 2018)745558
22-36476776-T-C not specified Uncertain significance (Jan 31, 2023)3185134
22-36476786-C-G Uncertain significance (Nov 13, 2021)1488709
22-36476796-G-A Likely benign (Aug 24, 2022)1909263
22-36476807-C-A not specified Uncertain significance (Jul 20, 2021)2411606
22-36476813-T-C Uncertain significance (Jan 15, 2024)1899123
22-36476817-C-T Likely benign (Jul 12, 2022)1925995
22-36476826-C-T Combined oxidative phosphorylation deficiency 29 • TXN2-related disorder Benign/Likely benign (Jul 01, 2024)774540
22-36476827-G-A Uncertain significance (Mar 04, 2022)2170439
22-36476865-GC-AG Likely benign (Nov 28, 2023)1895675
22-36476866-C-T Likely benign (Nov 07, 2023)731533

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TXN2protein_codingprotein_codingENST00000216185 314995
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00002560.3251257290181257470.0000716
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6157995.90.8230.000004991078
Missense in Polyphen1730.7160.55347371
Synonymous-0.6244439.01.130.00000219345
Loss of Function0.050877.150.9794.65e-767

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002130.000213
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.0001160.000114
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Important for the control of mitochondrial reactive oxygen species homeostasis, apoptosis regulation and cell viability. Possesses a dithiol-reducing activity. {ECO:0000269|PubMed:12032145, ECO:0000269|PubMed:12080052, ECO:0000269|PubMed:26626369}.;
Pathway
NOD-like receptor signaling pathway - Homo sapiens (human);Fluid shear stress and atherosclerosis - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Oxidative Stress;Detoxification of Reactive Oxygen Species;Cellular responses to stress;Degradation of cysteine and homocysteine;Metabolism of amino acids and derivatives;Metabolism;Cellular responses to external stimuli;Sulfur amino acid metabolism (Consensus)

Intolerance Scores

loftool
0.605
rvis_EVS
-0.36
rvis_percentile_EVS
28.63

Haploinsufficiency Scores

pHI
0.305
hipred
N
hipred_score
0.219
ghis
0.625

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.539

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Txn2
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype;

Gene ontology

Biological process
sulfur amino acid catabolic process;response to hypoxia;glycerol ether metabolic process;response to oxidative stress;response to hormone;response to glucose;response to organic cyclic compound;cellular response to nutrient levels;response to drug;cell redox homeostasis;response to axon injury;oxidation-reduction process
Cellular component
nucleolus;mitochondrion;mitochondrial matrix;dendrite;neuronal cell body
Molecular function
protein binding;peptide-methionine (S)-S-oxide reductase activity;protein disulfide oxidoreductase activity;peptide-methionine (R)-S-oxide reductase activity;protein-containing complex binding